NF-κB1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 1995-2003

  Artis, David ^a   Speirs, Kendra ^a   Joyce, Karen ^a   Goldschmidt, Michael ^a   Caamaño, Jorge ^b   Hunter, Christopher A ^a   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELL MATURATION; CELL PROLIFERATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LEISHMANIA MAJOR; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTOZOON; REGULATORY MECHANISM; T LYMPHOCYTE; TH1 CELL; WILD TYPE;

EID: 0037442135     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.1995     Document Type: Article

References (80)

1. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
2. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and Re1 proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225.
3. Karin, M. 1999. How NF-κB is activated: the role of the IKB kinase (IKK) complex, Oncogene 18:6867.
4. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621.
5. Karin, M., and M. Delhase. 2000. The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling. Semin. Immunol. 12:85.
6. Ghosh, S. 1999. Regulation of inducible gene expression by the transcription factor NF-κB. Immunol. Res. 19:183.
7. Caamaño, J., and C. A. Hunter, 2002, NF-κB family of transcription factors: central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev, 15:414.
8. Tato, C. M., and C. A. Hunter, 2002. Host-pathogen interactions: subversion and utilization of the NF-κB pathway during infection. Infect. Immun. 70:3311.
9. Weih, F., G. Warr, H. Yang, and R. Bravo. 1997. Multifocal defects in immune responses in Re1B-deficient mice. J. Immunol. 158:5211.
10. Caamaño, J., J. Alexander, L. Craig, R. Bravo, and C. A. Hunter. 1999. The NF-κB family member Re1B is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 163:4453.
11. Harling-McNabb, L., G. Deliyannis, D. C. Jackson, S. Gerondakis, G. Grigoriadis, and L. E. Brown. 1999. Mice lacking the transcription factor subunit Re1 can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response. Int. Immunol. 11:1431.
12. Attar, R. M., J. Caamaño, D. Carrasco, V. Iotsova, H. Ishikawa, R. P. Ryseck, F. Weih, and R. Bravo. 1997. Genetic approaches to study Re1/NF-κB/IκB function in mice. Semin. Cancer Biol. 8:93.
13. Speirs, K., J. Caamaño, M. H. Goldschmidt, C. A. Hunter, and P. Scott. 2002. NF-κB2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell differentiation. J. Immunol. 168:4406.
14. Artis, D., S. Shapira, N. Mason, K. M. Speirs, M. Goldschmidt, J, Caamaño, H. C. Liou, C. A. Hunter, and P. Scott. 2002. Differential requirement for NF-κB family members in control of helminth infection and intestinal inflammation. J. Immunol. 169:4481.
15. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
16. Louis, J., H. Hammelrich, C. Parra-Lopez, F. Tacchini-Cottier, and P. Launois. 1998. Regulation of protective immunity against Leishmania major in mice. Curr. Opin. Immunol. 10:459.
17. Scott, P. 1998. Differentiation, regulation, and death of T helper cell subsets during infection with Leishmania major. Immunol. Res. 17:229.
18. Grigoriadis, G., Y. Zhan, R. J. Grumont, D, Metcalf, E. Handman, C. Cheers, and S. Gerondakis. 1996. The Re1 subunit of NF-κB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Re1 in different macrophage populations. EMBO J. 15:7099.
19. Zheng, W., and R. A, Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587.
20. Farrar, J. D., W. Ouyang, M. Lohning, M. Assenmacher, A. Radbruch, O. Kanagawa, and K. M. Murphy. 2001. An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3. J. Exp. Med. 193:643.
21. Das, J., C. H. Chen, L. Yang, L. Cohn, P. Ray, and A. Ray. 2001. A critical role for NF-κB in GATA-3 expression and Th2 differentiation in allergic airway inflammation. Nat. Immun. 2:45.
22. Yang, L., L. Cohn, D. H. Zhang, R. Homer, A. Ray, and P. Ray. 1998. Essential role of NF-κB in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med. 188:1739.
23. Boothby, M. 2001. Specificity of sn50 for NF-κB? Nat. Immun. 2:471.
24. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor. T-bet, directs Th1 lineage commitment. Cell 100:655.
25. Mullen, A. C., F. A. High, A. S. Hutchins, H. W. Lee, A. V. Villarino, D. M. Livingston, A. L. Kung, N. Cereb, T. P. Yao, S. Y. Yang, and S. L. Reiner. 2001. Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science 292:1907.
26. Hilliard, B., E. B. Samoilova, T. S. Liu, A. Rostami, and Y. Chen. 1999. Experimental autoimmune encephalomyelitis in NF-κB-deficient mice: roles of NF-κB in the activation and differentiation of autoreactive T cells. J. Immunol. 163:29-37.
27. Sha, W. C., H. C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321.
28. Scott, P., E. Pearce, P. Natovitz, and A. Sher. 1987. Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract. J. Immunol. 139: 3118.
29. Shapira, S., K. Speirs, A. Gerstein. J. Caamaño, and C. A. Hunter. 2002. Suppression of NF-κB activation by infection with Toxoplasma gondii. J. Infect. Dis. 185(Suppl. 1):S66.
30. Tushinski, R. J., I. T. Oliver, L. J. Guilbert, P. W. Tynan, J. R. Warner, and E. R. Stanley. 1982. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28:71.
31. Warren, M. K., and S. N. Vogel. 1985. Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons. J. Immunol. 134:982.
32. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77.
33. Chace, J. H., N. A. Hooker, K. L. Mildenstein, A. M. Krieg, and J. S. Cowdery. 1997. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL- 12. Clin. Immunol. Immunopathol. 84:185.
34. Anitescu, M., J. H. Chace, R. Tuetken, A. K. Yi, D. J. Berg, A. M. Krieg, and J. S. Cowdery. 1997. Interleukin-10 functions in vitro and in vivo to inhibit bacterial DNA-induced secretion of interleukin-12. J. Interferon Cytokine Res. 17:781.
35. Green, L., D. Wagner, J. Glogowski, P. Skipper, J. Wishnok, and S. Tannebaum. 1982. Analysis of nitrate, nitrite, and (15N) nitrate in biological fluids. Anal. Biochem. 126:131.
36. Nacy, C. A., M. S. Meltzer, E. J. Leonard, and D. J. Wyler. 1981. Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/ HeN mouse macrophages. J. Immunol. 127:2381.
37. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171:131.
38. Chakkalath, H. R., C. M. Theodos, J. S. Markowitz, M. J. Grusby, L. H. Glimcher, and R. G. Titus. 1995. Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. J. Infect. Dis. 171:1302.
39. + T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158:5374.
40. Park, A. Y., B. D. Hondowicz, and P. Scott. 2000. IL-12 is required to maintain a Th1 response during Leishmania major infection. J. Immunol. 165:896.
41. Xie, Q. W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-κB/Re1 in induction of nitric oxide synthase. J. Biol. Chem. 269:4705.
42. Green, S. J., M. S. Meltzer, J. B. Hibbs, Jr., and C. A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:278.
43. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:4306.
44. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin-12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
45. Sypek, J. P., C. L. Chung, S. E. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
46. Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, J. A. Louis. and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553.
47. Sanjabi, S., A. Hoffmann, H. C. Liou, D. Baltimore, and S. T. Smale. 2000. Selective requirement for c-Re1 during IL-12 p40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA 97:12705.
48. Mason. N., J. Aliberti, J. C. Caamaño, H. C. Liou, and C. A. Hunter. 2002. Cutting edge: identification of c-Re1-dependent and -independent pathways of IL-12 production during infectious and inflammatory stimuli. J. Immunol. 168: 2590.
49. Bird, J. J., D. R. Brown, A. C. Mullen, N. H. Moskowitz, M. A, Mahowald, J. R. Sider, T. F. Gajewski, C. R. Wang, and S. L. Reiner. 1998. Helper T cell differentiation is controlled by the cell cycle. Immunity 9:229.
50. Grogan, J. L., M. Mohrs, B. Harmon, D. A. Lacy, J. W. Sedat, and R. M. Locksley. 2001. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14:205.
51. Sica, A., L. Dorman, V. Viggiano, M. Cippitelli, P. Ghosh, N. Rice, and H. A. Young. 1997. Interaction of NF-κB and NFAT with the interferon-γ promoter. J. Biol. Chem. 272:30412.
52. Cross, S. L., N. F. Halden, M. J. Lenardo, and W. J. Leonard. 1989. Functionally distinct NF-κB binding sites in the immunoglobulin κ and IL-2 receptor α chain genes. Science 244:466.
53. Verweij, C. L., M. Geerts, and L. A. Aarden. 1991. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J. Biol. Chem. 266:14179.
54. Lai, J. H., G. Horvath, J. Subleski, J. Bruder, P. Ghosh, and T. H. Tan. 1995. Re1A is a potent transcriptional activator of the CD28 response element within the interleukin-2 promoter. Mol. Cell Biol. 15:4260.
55. 1 phase of the cycle. J. Cell. Physiol. 154:7.
56. Boothby, M. R., A. L. Mora, D. C. Scherer, J. A. Brockman, and D. W. Ballard. 1997. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor NF-κB. J. Exp. Med. 185:1897.
57. Ferreira, V., N. Sidenius, N. Tarantino, P. Hubert, L. Chatenoud, F. Blasi, and M. Korner. 1999. In vivo inhibition of NF-ΚB in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis. J. Immunol. 162:6442.
58. Mora, A., J. Youn, A. Keegan, and M. Boothby. 2001. NF-κB/Re1 participation in the lymphokine-dependent proliferation of T lymphoid cells. J. Immunol. 166:2218.
59. Kontgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-Re1 proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965
60. Doi, T. S., T. Takahashi, O. Taguchi, T. Azuma, and Y. Obata. 1997. NF-κB Re1A-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1, and reduced proliferative responses. J. Exp. Me. 185:953.
61. Liou, H. C., Z. Jin, J. Tumang, S. Andjelic, K. A. Smith, and M. L. Liou. 1999. c-Re1 is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int. Immunol. 11:361.
62. Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621.
63. Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
64. Gerondakis, S., A. Strasser, D. Metcalf, G. Grigoriadis, J. Y. Scheerlinck, and R. J. Grumont. 1996. Re1-deficient T cells exhibit defects in production of interleukin-3 and granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 93:3405.
65. Franzoso, G., V. Bours, S. Park, M. Tomita-Yamaguchi, K. Kelly, and U. Siebenlist. 1992. The candidate oncoprotein Bcl-3 is an antagonist of p50/ NF-κB-mediated inhibition. Nature 359:339.
66. + T lymphocytes. Science 256:1452.
67. Ishikawa, H., E. Claudio, D. Dambach, C. Raventos-Suarez, C. Ryan, and R. Bravo. 1998. Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-κB1) but expressing p50. J. Exp. Med. 187:985.
68. Kastenbauer, S., and H. W. Ziegler-Heitbrock. 1999. NF- κB1 (p50) is up-regulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression. Infect. Immun. 67:1553.
69. Arima, N., W. A. Kuziel, T. A. Grdina, and W. C. Greene. 1992. IL-2-induced signal transduction involves the activation of nuclear NF-κB expression. J. Immunol. 149:83.
70. Nakajima, H., X. W. Liu, A. Wynshaw-Boris, L. A. Rosenthal, K. Imada, D. S. Finbloom, L. Hennighausen, and W. J. Leonard. 1997. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction. Immunity 7:691.
71. Perkins, N. D., L. K. Felzien, J. C. Betts, K. Leung, D. H. Beach, and G. J. Nabel. 1997. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523.
72. Joyce, D., C. Albanese, J. Steer, M. Fu, B. Bouzahzah, and R. G. Pestell. 2001. NF-κB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev. 12:73.
73. Guttridge, D. C., C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin, Jr. 1999. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell Biol. 19:5785.
74. 1-to-S-phase transition. Mol. Cell. Biol. 19:2690.
75. Reiner, N. E., and J. H. Finke. 1983. Interleukin-2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin. J. Immunol. 131:1487.
76. Cillari, E., F. Y. Liew, and R. Lelchuk. 1986. Suppression of interleukin-2 production by macrophages in genetically susceptible mice infected with Leishmania major. Infect. Immun. 54:386.
77. Belosevic, M., D. S. Finbloom, M. S. Meltzer, and C. A. Nacy. 1990. IL-2: a cofactor for induction of activated macrophage resistance to infection. J. Immunol. 145:831.
78. Murray, H. W., G. D. Miralles, M. Y. Stoeckle, and D. F. McDermott. 1993. Role and effect of IL-2 in experimental visceral leishmaniasis. J. Immunol. 151:929.
79. Modlin. R. L., F. J. Tapia, B. R. Bloom, M. E. Gallinoto, M. Castes, A. J. Rondon, T. H. Rea, and J. Convit. 1985. In situ characterization of the cellular immune response in American cutaneous leishmaniasis. Clin. Exp. Immunol. 60:241.
80. Nilsen, R., and R. N. Mshana. 1987. In situ characterization of the cutaneous immune response in Ethiopian cutaneous leishmaniasis. Scand. J. Immunol. 26:503.